Antagonistic Effect of the Matricellular Signaling Protein CCN3 on TGF-β- and Wnt-Mediated Fibrillinogenesis in Systemic Sclerosis and Marfan Syndrome  by Lemaire, Raphael et al.
Antagonistic Effect of the Matricellular Signaling
Protein CCN3 on TGF-b- and Wnt-Mediated
Fibrillinogenesis in Systemic Sclerosis and
Marfan Syndrome
Raphael Lemaire1,2, Giuseppina Farina1, Julie Bayle1, Michael Dimarzio1, Sarah A. Pendergrass3,
Ausra Milano3, Michael L. Whitfield3 and Robert Lafyatis1
Abnormal fibrillinogenesis is associated with connective tissue disorders (CTDs), including Marfan syndrome
(MFS), systemic sclerosis (SSc) and Tight-skin (Tsk) mice. We have previously shown that TGF-b and Wnt
stimulate fibrillin-1 assembly and that fibrillin-1 and the developmental regulator CCN3 are both highly
increased in Tsk skin. We investigated the role of CCN3 in abnormal fibrillinogenesis in Tsk mice, MFS, and SSc.
Smad3 deletion in Tsk mice decreased CCN3 overexpression, suggesting that TGF-bmediates at least part of the
effect of Tsk fibrillin on CCN3 which is consistent with a synergistic effect of TGF-b and Wnt in vitro on CCN3
expression. Disruption of fibrillin-1 assembly by MFS fibrillin decreased CCN3 expression and skin from
patients with early diffuse SSc showed a strong correlation between increased CCN3 and fibrillin-1 expression,
suggesting that CCN3 regulation by fibrillin-1 extends to these CTDs. Diffuse SSc skin and sera also showed
evidence of increased Wnt activity, implicating a Wnt stimulus behind this correlation. CCN3 overexpression
markedly repressed fibrillin-1 assembly and also blocked other TGFb- and Wnt-regulated profibrotic gene
expression. Together, these data indicate that CCN3 counter-regulates positive signals from TGF-b and Wnt for
fibrillin fibrillogenesis and profibrotic gene expression.
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INTRODUCTION
Microfibrils, 10–12 nm in diameter are important structural
and functional components of the extracellular matrix of a
wide range of connective tissues, including skin, bones, and
aorta. The largest components of microfibrils are the fibrillins,
including fibrillin-1 and -2 (Sakai et al., 1986; Zhang et al.,
1994). The association of mutations in the fibrillin-1 gene
with connective tissue disorders (CTDs) illustrates the
important function of fibrillin-1 in tissue development and
extracellular matrix remodeling. Marfan syndrome (MFS), an
autosomal hereditary CTD with prominent manifestations
in the skeletal, cardiovascular, and ocular systems, is caused
by fibrillin-1 mutations and is associated with reduced
amount of fibrillin-1 deposited in the matrix (Lemaire
et al., 2006). Fibrillin-1 mutations are also present in
populations with the highest reported prevalence of systemic
sclerosis (SSc), a CTD characterized by skin fibrosis and
increased amounts of fibrillin deposited in the deep reticular
dermis (Fleischmajer et al., 1991; Davis et al., 1999). How
mutations in fibrillin-1 induce matrix remodeling is unclear.
The study of fibrillin-deficient mice suggests that mutant
fibrillin matrix may lead to faulty growth factor signaling.
Aneurysm caused by the C1039G fibrillin-1 mutation in a
mouse model of MFS is associated with decreased levels
of microfibrils and increased levels of TGF-b signaling
(Ng et al., 2004).
We have recently shown that skin fibrosis, bone over-
growth, and heart enlargement caused by a large duplication
within the fibrillin-1 gene in the tight skin (Tsk) mouse model
of SSc is developmentally regulated and associated with
dramatically increased fibrillin-1 and Wnt levels. Further-
more, we showed that Wnts stimulate fibrillin-1 matrix
assembly (Bayle et al., 2008). However, the most highly
upregulated gene expression by microarray analysis of Tsk
skin was CCN3, a growth factor belonging to the CCN (Cyr-
61/Ctgf/Nov) family of developmental regulators (Brigstock,
1999; Lau and Lam, 1999; Perbal, 2001). We show here that
overexpression of fibrillin-1 in Tsk skin is temporally and
spatially associated with a similar overexpression of CCN3,
suggesting that CCN3 regulates Tsk matrix remodeling.
ORIGINAL ARTICLE
1514 Journal of Investigative Dermatology (2010), Volume 130 & 2010 The Society for Investigative Dermatology
Received 3 March 2009; revised 2 December 2009; accepted 21 December
2009; published online 25 February 2010
1Rheumatology Section, The Arthritis Center, Boston University School of
Medicine, Boston, Massachusetts, USA; 2Inflammation and Autoimmune
Group, Research Department, MedImmune, Gaithersburg, Maryland, USA
and 3Department of Genetics, Dartmouth Medical School, Hanover, New
Hampshire, USA
Correspondence: Robert Lafyatis, Department of Genetics, Boston University
School of Medicine, Rheumatology section iV E5, 72 E Newton Street, Boston,
Massachusetts 02218, USA. E-mail: lafyatis@bu.edu
Furthermore, we show that TGF-b and Wnt may work
synergistically to stimulate CCN3 in Tsk skin. However, in
contrast with TGF-b and Wnt, we show that CCN3 represses
fibrillin-1 matrix assembly. We also show that mRNA levels
of Wnt2 and the Wnt-regulated gene, WISP1, are increased in
the skin of patients with diffuse cutaneous SSc, and that the
expression of CCN3 and fibrillin-1 correlates strongly in early
diffuse SSc skin and in an in vitro model of MFS, suggesting
that CCN3 may represent a counter-regulatory mechanism
to the stimulating effects of TGF-b and Wnt on fibrillin
fibrillinogenesis in CTDs.
RESULTS
Spatial and temporal correlation of CCN3 and fibrillin-1
overexpression in Tsk mice
Our recent microarray data have shown that, along with
fibrillin-1, CCN3 features the highest increase among over-
expressed genes in skin of Tsk mice (Bayle et al., 2008). Here,
we confirmed these microarray data using northern and
western blot analysis of CCN3 in Tsk compared with
wild-type skin of 6-week-old mouse littermates. CCN3 was
increased about 15-fold at the mRNA level (Figure 1a, left
panel) and 16-fold at the protein level (Figure 1a, right panel).
Immunochemistry showed that this dramatic increase in
CCN3 was mainly located in the hypodermis of Tsk skin
(Figure 1b), similar to what is seen for fibrillin-1 (Lemaire
et al., 2004b). A strong parallel between increased expression
of CCN3 and increased fibrillin-1 expression was seen in
the skin, as well as in skeletal muscle, heart, and bones of
Tsk mice (Figure 1c and d). Although CCN3 expression
was highest in the brain, fibrillin-1 expression was very low in
this tissue and neither CCN3 nor fibrillin-1 showed any
alteration in levels of expression. Both CCN3 and fibrillin-1
also showed developmental regulation and were over-
expressed in Tsk skin as soon as 18.5-day embryonic age
and thereafter (Figure 1e). The spatial and temporal correla-
tion of CCN3 and fibrillin-1 overexpression in Tsk mice
suggested an important functional relationship of these two
genes for the onset of the Tsk pathology.
Deletion of Smad3 in Tsk mice reduces CCN3 and fibrillin
overexpression in Tsk mice
We assessed whether TGF-b contributes to the effect of Tsk
fibrillin on CCN3 expression by looking at CCN3 expression
in Tsk mice deleted of Smad3, a key TGF-b intracellular
signaling molecule. Deletion of a single Smad3 allele did
not alter overexpression of CCN3 in Tsk skin compared
with wild-type skin (Figure 2a, Smad3þ /, WT vs TSK).
However, deletion of both Smad3 alleles in Tsk skin largely
reduced CCN3 overexpression (Figure 2a, Smad3/, WT vs
TSK). Interestingly, both mutant and wild-type fibrillin
followed the same expression pattern, as deletion of both
Smad3 alleles in Tsk skin also largely reduced fibrillin-1
overexpression (Figure 2a, Smad3/, WT vs TSK), suggest-
ing that TGF-b contributes to increased CCN3 and fibrillin-1
in Tsk skin. However, the importance of TGF-b appears to be
restricted to early developmental time points as blocking
TGF-b after birth using neutralizing anti-TGF-b antibodies
or induced deletion of the TGF-b receptor after birth did
not produce reproducible changes in CCN3 expression
(R. Lafyatis, unpublished observations). This is consistent
with the observation that the Tsk phenotype is detectable at
birth. To further investigate the potential for TGF-b to drive
increased CCN3 in Tsk skin, we assessed the effect of
TGF-b on CCN3 expression in vitro. Treatment of cultured
fibroblasts with TGF-b alone did not stimulate CCN3 expres-
sion. As canonical Wnt signaling can interact with the Smad
pathway (Furuhashi et al., 2001; Gadue et al., 2006) and
we have recently shown that Wnt signaling is altered in Tsk
skin (Bayle et al., 2008), we then tested the effect of Wnt3a
on CCN3 expression. Treatment of fibroblasts with Wnt3a-
CCN3 mRNA
CC
N3
 m
RN
A
CCN3 protein
CC
N3
 p
ro
te
in
Total protein
W
T
WT
WT
W
T
W
T
W
T
W
T
W
T
W
T
W
T
W
T
Ts
k
TSK
TSK fibrillin
TSK fibrillin
WT fibrillin-1
WT fibrillin-1
CCN3
18S
4 WeeksE18.5
Bone
CCN3
CCN3
18S
18S
TS
K
TS
K
TS
K
TS
K
TS
K
Ts
k
W
T
TS
K
TS
K
TS
K
Brain
Skeletal
muscleSpleen Heart Skin Kidney
WT TskTsk
W
T
Ts
k
18S rRNA
14.46
sf sf
1.00 1.00
16.2020
a
b
c
d e
16
12
8
4
0
20
16
12
8
4
0
Figure 1. Spatial and temporal correlation of CCN3 overexpression in Tsk
mice. (a) Tsk and wild-type (WT) skins were analyzed for CCN3 mRNA and
protein expression, respectively, by northern blot (left panel) and western blot
(right panel). (b) Tsk and WT skin samples were analyzed for CCN3 by
immunohistochemistry (sf: hypodermis (scale bar¼ 100mM)). (c and d) Brain,
spleen, skeletal muscle, heart, skin, kidneys, and bones from Tsk and WT
mice were analyzed for both fibrillin and/or CCN3 mRNAs by northern blot.
(e) Tsk and WT skin samples were analyzed for both fibrillin and/or CCN3
at 18.5 embryo age stage and 4 weeks after birth by northern blot.
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stimulated CCN3 mRNA expression by 3-fold, and TGF-b
acted synergistically with Wnt3 to induce CCN3 expression
by more than 6-fold (Figure 2b). These data suggested that the
TGF-b and Wnt may co-mediate the stimulating effect of Tsk
fibrillin on CCN3 expression.
Disruption of fibrillin-1 matrix assembly by MFS-like fibrillin
correlates with decreased expression of CCN3
On the basis of the correlation between increased CCN3 and
fibrillin-1 expression in Tsk skin, heart, and muscle, suggest-
ing a function of CCN3 in fibrillinopathy, we then assessed
CCN3 expression in MFS, a human fibrillinopathy caused by
mutations in the fibrillin-1 gene. For these studies, we used an
in vitro model of MFS recently developed by our group that
features a doxycycline (dox)-regulated system allowing
cultured fibroblasts to conditionally overexpress a Marfan-
like fibrillin deletion mutant, where the C-terminal region
is replaced at amino acid 2780 by EGFP. Overexpression of
this MFS fibrillin mutant prevents matrix assembly of wild-
type fibrillin-1 (Lemaire et al., 2007) similar to what is seen in
Marfan tissues. Briefly, in the presence of dox, expression of
the MFS fibrillin mutant is repressed (Figure 3a, A) and
associated with deposition of a complex and thick fibrillin
network, as wild-type fibrillin-1 assembles within the matrix
(Figure 3a, C, red staining). However, in the absence of
dox, MFS fibrillin is overexpressed (Figure 3a, B, intracellular
green staining), preventing matrix assembly of wild-type
fibrillin-1 (Figure 3a, D). Expression of MFS fibrillin and
therefore disruption of fibrillin matrix assembly was asso-
ciated with markedly decreased CCN3 mRNA expression
(Figure 3b, dox þ vs dox ). This decrease in CCN3 was
MFS-fibrillin dose-dependent (Figure 3b, low MFS fibrillin
producing MEFMSF1 cell line versus high MFS fibrillin-
producing MEFMSF2 cell line).
Expression of CCN3 and fibrillin-1 expression correlates in early
diffuse SSc skin
Diffuse SSc skin shows increased levels of fibrillin-1 microfibrils
in the deep dermis (Fleischmajer et al., 1991; Davis et al.,
1999). Therefore, we looked at whether the correlation between
CCN3 and fibrillin-1 seen in murine Tsk and human MFS
fibrillinopathies could be extended to SSc. Microarray analysis
of CCN3 and fibrillin-1 mRNA levels in skin was performed
using forearm lesional and back non-lesional biopsies from
eight patients with early diffuse SSc, nine patients with late
diffuse SSc, seven patients with limited SSc and six healthy
control individuals (Figure 4a, left panel) (Milano et al., 2008).
Microarray expression showed no significant difference
between CCN3 or fibrillin-1 expression in skin from patients
with limited or diffuse SSc (see Supplementary Figure S1A
online, right panel). However, the average levels of CCN3 and
fibrillin-1 in early diffuse SSc skin were slightly increased
compared with healthy skin, and CCN3 expression correlated
highly with fibrillin-1 expression (R2¼ 0.80, P¼0.002, Supple-
mentary Figure S1B, upper left panel), unlike late diffuse SSc,
limited SSc, and healthy skin (Supplementary Figure S1B,
respectively upper right, lower left and lower right panels). To
more quantitatively assess this relationship, RNA from skin
samples of patients with early diffuse SSc were analyzed for
CCN3 and fibrillin-1 expression by RT-PCR. CCN3 showed 2.2-
and fibrillin-1 2.4-fold greater expression in dSSc skin compared
with healthy control skin (Figure 4). More strikingly, however,
and confirming the microarray data, CCN3 expression corre-
lated highly with fibrillin-1 expression (Figure 4, R2¼0.51).
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Figure 2. Deletion of Smad3 in Tsk mice reduces CCN3 and fibrillins
overexpression in Tsk mice. (a) Skin samples from Tsk and WT mice deleted
one Smad3 allele (Smad3þ /) or two Smad3 alleles (Smad3þ /þ ) were
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fibroblasts (MEF) were left untreated or treated with TGF-b (2 ngml1),
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mRNA expression by northern blot.
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Wnt activity is increased in diffuse SSc
We have previously shown that Tsk skin expresses increased
levels of Wnt and Wnt-regulated genes. To assess whether
Wnt stimulation of fibrillin-1 and CCN3 might underlie
the correlation between fibrillin-1 and CCN3 in diffuse
SSc skin, we looked at Wnt signaling and activity in
diffuse SSc. For these studies we analyzed mRNA expression
of 84 Wnt-related genes in forearm skin biopsies from 12
diffuse SSc patients and five healthy individuals using Wnt
Signaling Pathway Real-Time PCR array. Statistical analysis
using a t-test corrected for multiple hypothesis testing
(significance analysis of microarrays, SAM, qo0.01%,
http://www-stat.stanford.edu/~tibs/SAM/) showed statistically
significant changes in expression for nine genes in SSc
compared with healthy skin, (Figure 5a, upper left panel).
Among these genes, three genes showed increased expres-
sion, including Sfrp4, Wnt2, and Wisp1 (Wnt-inducible
protein 1, also called CCN4) (Figure 5a, upper right panel).
This expression pattern is similar to that seen in Tsk skin,
which shows increased levels of Sfrp4, Wnt2, and Wisp2
(also called CCN5) (Bayle et al., 2008). Interestingly, Wnt 2
and Sfrp4 (a Wnt inhibitor) significantly correlated (Figure 5a,
lower left panel), suggesting that these two molecules might
control net levels of Wnt activity in SSc. SSc skin also showed
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SSc skin. Expression of CCN3 (a) and fibrillin-1 (b) in lesional (20 biopsies)
and control skin (6 biopsies). Fold-change shown on the graph is normalized
to mRNA expression to one of the healthy controls. The average fold change
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healthy skin (0.86), was increased by 2.2-fold (Po0.05). The average fold
change of fibrillin-1 in SSc skin (1.86) compared with the average fold change
in control, healthy skin (0.66), was increased by 2.4-fold (Po0.01).
Correlation between fibrillin-1 and CCN3 expression (c, R2¼0.51).
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significant decreases in six genes, including Wif1 and Frzb.
These two inhibitors of Wnt activity showed the two largest
decreases, possibly also contributing to increased net Wnt
activity in diffuse SSc skin (Figure 5a, lower right panel).
This is consistent with increased levels of Wisp1, the only
Wnt-regulated gene tested on these arrays and possibly
a biomarker of Wnt activity.
To further investigate the possibility that Wnt activity
is increased in SSc, we measured Wnt activity in sera of 24
patients with diffuse SSc and eight healthy individuals using
Wnt reporter LSL cells (Blitzer and Nusse, 2006). Diffuse SSc
sera showed a modest but statistically significant 1.56-fold
increase in Wnt activity compared with healthy individual
sera (P¼ 0.00001) (Figure 5b). As Wnt activity was higher in
diffuse SSc skin and Wnt regulates both fibrillin-1 (Bayle
et al., 2008) and CCN3 (Figure 2b), Wnt represents a good
candidate to mediate the correlation between fibrillin-1 and
CCN3 in early SSc skin.
CCN3 overexpression represses fibrillin-1 matrix assembly
Based on the above data showing a strong correlation
between CCN3 and fibrillin-1 in Tsk mice, and early diffuse
SSc, we hypothesized that an important function of CCN3
is to regulate fibrillin-1 levels in connective tissues.
We analyzed the effect of CCN3 on fibrillin-1 using dox-
regulated cell lines conditionally overexpressing CCN3. In
the absence of dox treatment, cells overexpressed CCN3. In
the presence of dox, CCN3 was entirely repressed (Figure 6a
and b). Cells not expressing exogenous CCN3 showed a
strong and extended fibrillin-1 network in the matrix (Figure
6b, a, red staining). In contrast, cells expressing high levels of
endogenous CCN3 showed a poor and limited fibrillin-1
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Figure 5. Wnt activity is increased in diffuse SSc. (a) Skin biopsies from patients with diffuse SSc (n¼12) and from control healthy individuals (n¼ 5)
were analyzed for expression of 84 genes of the Wnt-signaling pathway by real-time PCR array. Expression of nine genes differed significantly in SSc
skin compared with control skin (SAM, qo0.01%) (upper left panel), including three genes with increased expression in SSc skin (upper right panel) and
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presented in lower left panel. (b) Sera from 25 SSc patients (n¼ 25) and healthy individuals (n¼ 8) were analyzed for Wnt activity using LSL luciferase
reporter cells. *Po0.05.
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matrix network (Figure 6b, B). Northern blot analysis showed
that this strong repressive effect of CCN3 on fibrillin-
associated matrix was independent of fibrillin-1 expression,
as CCN3 overexpression did not affect fibrillin-1 mRNA
levels (Figure 6c) or protein levels (data not
shown), suggesting that CCN3 affects fibrillin-1 assembly.
As fibrillin-1 is the main component of elastic fibers, we
also looked at the effect of CCN3 elastic fibers assembly
synthesized from exogenous tropoelastin-EGFP. Consistent
with the effect of CCN3 on fibrillin-1, overexpression of
CCN3 strongly reduced elastic fibers assembly (Figure 6b,
C vs D, green staining).
CCN3 inhibits TGFb- and Wnt-induced gene expression
To gain further insight into the mechanism of CCN3 inhi-
bition of TGFb- and Wnt-induced fibrillogenesis, we exami-
ned the effect of CCN3 on expression of genes regulated by
these cytokines in mouse fibroblasts. Wnt3a upregulated MEF
cell expression of CCN3 as shown above (Figure 2b), and
connective tissue growth factor (CTGF/CCN2), endothelin-1
(ET-1) and smooth muscle actin (SMA) as reported previously
(Chen et al., 2007). CCN3 completely blocked Wnt-induced
CCN3, partially blocked Wnt-induced ET-1, and had little
effect on Wnt-induced SMA and CTGF (Figure 7a). CCN3
also partially inhibited TGFb-induced CCN2 expression
(Figure 7b). In addition, CCN3 also strongly inhibited the
Wnt-inducible TOPFLASH promoter (Figure 7c), however,
had no effect on TGFb-induced promoter activity of the PAI-1
promoter-reporter in TMLC cells (data not shown).
DISCUSSION
Defining the factors that mediate fibrillin expression and
matrix assembly is a necessary step for better understanding
CTDs. We have previously shown that TGFb regulates
fibrillin-1 assembly (Kissin et al., 2002), consistent with data
showing that increased TGFb activity contributes to the
pathology of MFS (Neptune et al., 2003). In Tsk mice the role
of TGFb in altered fibrillogenesis is likely required at a point
during early mouse skin development that ends or is largely
attenuated before or shortly after birth, based on our inability
to block increased CCN3 expression using strategies targeting
5-day and older mice. This is consistent with our observation
that the Tsk phenotype and increased CCN3 expression are
detectable at birth. In SSc many studies have suggested that
TGFb mediates tissue fibrosis, and it may also account for
increased fibrillin–microfibrils in the deep dermis of SSc skin.
However, other cytokines may also contribute to altered
fibrillin deposition in these diseases. We have recently shown
that Wnt signaling is altered in Tsk mice, specifically in
fibrillin-containing tissues, including skin, heart, and skeletal
muscles, suggesting that Wnts may mediate tissue fibrosis in
Tsk mice. Accordingly, we have also shown that Wnt3a
stimulates matrix assembly of fibrillin-1, independently of
fibrillin-1 transcription (Bayle et al., 2008). A role for Wnts in
skin fibrosis is further suggested by studies showing that
Wnt3a induces CTGF, TGFb, and ET-1 (Chen et al., 2007).
Interestingly, we show here that Wnt2 and a marker of
Wnt activity in the skin, Wisp1, are increased and genes
associated with Wnt inhibition, Wif1 and Frzb, decreased
in SSc skin. In addition, we show that serum Wnt activity is
modestly but significantly increased in SSc patient sera.
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Although changes in Wnt activity in serum are modest, they
are similar in magnitude to changes seen in aged mice
associated with fibrosis of muscles (Brack et al., 2007).
Together these data suggest that Wnt may contribute to the
increase in fibrillin–microfibril assembly in the deep dermis of
SSc skin, and are consistent with past observations suggesting
a Wnt signature in scleroderma skin (Gardner et al., 2006).
Wnts have other profibrotic activities including their direct
effects on fibrotic gene expression (Chen et al., 2007), but
also effects on cell differentiation (Brack et al., 2007),
indicating potential important roles beyond altered fibrillo-
genesis in SSc.
Wnt- and TGF-b-signaling pathways can interact through
several mechanisms (Nishita et al., 2000; Furuhashi et al.,
2001; Gadue et al., 2006), possibly accounting for synergistic
effects of these cytokines on CCN3 expression. The best-
defined involves Smad4 (a ‘‘co-Smad’’ important in signaling
by TGF-b-stimulated Smad2/3) forming a complex with Lef1/
Tcf and b-catenin (Nishita et al., 2000). Another study has
shown the interaction of Smad4 with Lef1/Tcf regulates
downstream gene expression in the absence of TGF-b (Lim
and Hoffmann, 2006).
Along with TGF-b and Wnt, CCN3 may represent another
signaling pathway important in fibrillinopathies. We show
here a high correlation between increased fibrillin-1 and
increased CCN3 expression in Tsk skin, early diffuse SSc skin
and in an in vitro model of MFS. Consistent with a role of
CCN3 in fibrillinogenesis, we also show that CCN3 over-
expression represses fibrillin-1 matrix assembly. Interestingly,
this repressive function of CCN3 is in contrast to the stimu-
lating activity of TGF-b and Wnt on fibrillin assembly,
suggesting that CCN3 provides a counter regulatory mecha-
nism to the stimulating effect of TGF-b and Wnt on fibrillin-1
assembly in fibrillinopathies (see Figure 8). Tight control
exerted in concert by TGF-b and Wnt (positive regulators)
and CCN3 (negative regulator) on fibrillin-1 matrix assembly
may account for the correlation between fibrillin-1 and
CCN3 expression in early diffuse SSc skin. This counter-
regulatory role of CCN3 appears to extend beyond fibrillo-
genesis and includes other Wnt and TGFb targets, including
CCN3 itself, and ET1 and CCN2, respectively. The effect
of CCN3 on CCN2 expression may be particularly important,
as recent observations suggest that CCN3 inhibition of
CCN2 may lead to downregulation of TGFb-mediated fibrosis
(Riser et al., 2009).
Our data provide some insights into the mechanism of
how CCN3 downregulates TGFb and Wnt signals. Despite
the effect of smad3 deletion on fibrillin expression in Tsk
mice, it seems unlikely that CCN3 downregulates TGFb
activity through smad2/3, as the PAI-1 promoter–reporter
construct in TMLC cells is activated by smad2/3 (Chen et al.,
1996), but was not affected by CCN3. Recently published
Control
Wnt3
CCN3
CON CCN3 TGFβ CCN3+
TGFβ
CCN3 CCN2 ET-1 SMA
40a
b
c
35
30
25
20
15
10
5
0
40
30
20
10
0
500
400
300
200
100
0
Co
ntr
ol
Wn
t 3
A (0
.8 n
g/m
l)
Wn
t 3
A (8
 ng
/ml) CC
N3
Wn
t 3
A +
 CC
N3
CCN3+Wnt3
Fo
ld
 c
ha
ng
e
CC
N2
 fo
ld
 c
ha
ng
e
Lu
ci
fe
ra
se
 a
ct
iv
ity
Figure 7. Regulation of Wnt- and TGFb-induced gene expression by CCN3.
(a) Mouse embryonic fibroblasts (MEF) treated 24hours with Wnt3a
(50 ngml1), CCN3 (10 mgml1), neither, or both were analyzed for CCN3,
CTGF (CCN2), endothelin-1 (ET-1), and smooth muscle actin (SMA) gene
expression by RT-PCR. (b) MEF cells treated 24 hours with TGFb (2 ngml1),
CCN3 (10 mgml1), neither, or both were analyzed for CTGF/CCN2
expression by RT-PCR. (c) Luciferase activity of Wnt promoter-reporter (LSL)
cells, treated 24hours with Wnt3a (0.08 or 8 ngml1), CCN3 (10 mgml1),
or Wnt3a (8 ngml1) and CCN3 (10 mgml1).
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Figure 8. Counter-regulatory role of CCN3 in matrix formation. TGFb
and Wnt stimulate fibrillin and collagen matrix, whereas CCN3 blocks
effects of both the cytokines. Fibrillin matrix upregulates CCN3,
providing a homeostatic feedback mechanism for controlling extracellular
matrix.
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observations support this interpretation, showing that
CCN3 inhibits TGFb-mediated signals, but does not alter
smad3 phosphorylation (Riser et al., 2009). Smad-indepen-
dent signaling provides many other targets for such regulation
(Derynck and Zhang, 2003). Strong inhibition of the TOP-
Flash promoter–reporter in LSL cells by CCN3 suggests that
CCN3 downregulates Lef1/Tcf, the primary signaling trans-
cription factor in canonical Wnt signaling regulating this
promoter (Oosterwegel et al., 1991).
The function of CCN3 in fibrillin microfibril assembly
described in this study is in line with a broader role of
CCN3 in matrix biology and CTDs, as targeted disruption of
CCN3 in mice causes abnormal development of bones, heart,
and skeletal muscles (Lin et al., 2005), the same tissues that
are altered in Tsk mice.
In conclusion, this report defines an important and
previously unknown function of CCN3 in extracellular
homeostasis that is relevant to CTDs, including SSc and
MFS. Further understanding of the interaction of CCN3 with
TGF-b and Wnt should provide new insight into these
sometimes lethal diseases.
MATERIALS AND METHODS
Patients and controls
All patients with diffuse and limited SSc met the American College
of Rheumatology criteria for SSc. Early diffuse SSc was defined by
disease duration o3 years based on the onset of non-Raynaud’s
symptoms. The control healthy individuals had no history of skin
disease. Skin punch biopsies were obtained from lesional regions of
the dorsal mid-forearm and non-lesional regions of the back.
Biopsies were performed after the patient’s written consent and
with approval of the Boston University Medical Center Institutional
Review Board for Human Studies. The study was conducted
according to the Declaration of Helsinki Principles.
Mice
Heterozygous tight skin (B6Fbn1Tskþ /þ Pldnpa) mice originally
purchased from Jackson Laboratory (Bar Harbor, ME) were bred to
the B6 mice harboring the closely linked pallid mutation
pa (B6þ Pldnpa/þ Pldnpa) and identified by genotyping and manual
assessment of skin tightness over the back. Mouse experiments were
conducted under a protocol approved by the Boston University,
Institutional Animal Care And Use Committee.
Cells and plasmids
Dox-regulated cells overexpressing CCN3 were developed from
a mouse embryonic fibroblast line (MEF 3T3, Clontech, Palo Alto,
CA) that harbors the pTET-Off regulator, plasmid expressing
a tet-controlled transactivator protein that binds to promoter
tet-responsive element (TRE). These MEF cells were transfected with
pTRE2–CCN3, a vector supporting dox-regulated TRE-driven expres-
sion of CCN3. pTRE2–CCN3 was constructed by inserting a 2.3-kb
mouse CCN3 cDNA (MGC-5979, ATCC, Manassas, VA) as a blunted
SalI/NotI fragment into pTRE2 (Clontech) at blunted BamHI/NotI
sites. MEF–MFS cells conditionally overexpressing MFS fibrillin were
developed by transfecting MEF cells with pTRE–MFS–Fbn–EGFP, a
vector-supporting dox-regulated TRE-driven expression of the C
terminus-truncated fibrillin-1 mutant (Lemaire et al., 2007).
Cell transfection
Cell lines were transfected using lipofectamine plus reagent
(Invitrogen, Carlsbad, CA). After transfection, cells were selected
for 12–14 days using G418 (100mgml–1) and Hygromycin
(60 mgml–1). A total of 40–50 selected cell colonies were then ring-
cloned, expanded, and analyzed for the transfected gene by northern
blot and western blot.
Immunofluorescence
Cells were grown in Lab-Tek 8-chamber culture slides (Nalge
Nunc International, Naperville, IL), fixed for 10minutes in
paraformaldehyde at room temperature, blocked for 30minutes
with 3% BSA in TBS, and then incubated for 2 hours with poly-
clonal rabbit Ab9543 antisera directed against mouse fibrillin-1 (gift
of Lynn Sakai) (Lemaire et al., 2004a). Cells were washed
three times with TBS for 5minutes, incubated for 1 hour with a
rhodamine-conjugated donkey anti-rabbit IgG at a 1/200 dilution.
Specific fluorescence signals were then visualized by an
Olympus BH-2 microscope under fluorescent light and captured
with high resolution Olympus DP70 camera. Exposure times
were set manually and were identical between dox þ and dox 
conditions.
Immunohistochemistry
Tissues were fixed overnight to several days in buffered 4%
paraformaldehyde and then embedded in paraffin. Sections
were cut, mounted on uncoated slides, and hydrated by passage
through xylene and graded ethanols. Sections were incubated
with polyclonal rabbit anti-sera directed against CCN3 (1/1000
dilution, gift of B. Perbal) for 2 hours in a humidified chamber,
and washed three times with TBS for 10minutes. Sections were
then incubated for 1 hour with anti-rabbit alkaline phosphatase-
labeled polymer and stained using Fast Red (Envision, Dako
Laboratory, Carpinteria, CA). Tissues were counterstained in
Mayer’s Hematoxylin (DAKO, Glostrup, Denmark) and viewed
under an Olympus DP70 camera.
SDS-polyacrylamide gel electrophoresis (PAGE) and
immunoblotting
Cells were directly homogenized and lysed in SDS-PAGE buffer/2%
b-mercaptoethanol. Proteins were resolved on a 10% SDS-PAGE gel,
transferred to nitrocellulose, and then incubated with primary
polyclonal rabbit antisera directed against mouse CCN3 (1/500
dilution). The secondary antibody consisted of a secondary horse-
radish peroxidase-conjugated donkey anti-mouse IgG antibody
(1/10,000). Signal was detected using Supersignal West Pico
or Femto Chemiluminescent Reagent (Pierce, Rockford, IL) followed
by autoradiography.
RNA analysis
Total RNA was extracted and purified from mouse or human
tissues using RNeasy Total RNA kit (Qiagen, Valencia, CA), as
previously described (Bayle et al., 2008). RNAs were then separated
by electrophoresis through a 1M formaldehyde/1% agarose gel and
blotted onto a nylon membrane (Hybond-H, Amersham Biosciences,
Piscataway, NJ). Blotted RNAs were then hybridized to random
primed 32P-labeled cDNA probes for either mouse fibrillin-1 and
CCN3, as previously described (Kissin et al., 2002). Signals were
www.jidonline.org 1521
R Lemaire et al.
Antagonistic Effect of the Matricellular Signaling Protein
analyzed and quantified using a Phosphoimager (Cyclone, Packard
Biosciences, Waltham, MA).
RT-PCR and Wnt RT-PCR array
cDNAs were synthesized from 0.05 mg of total skin RNA using
Superscript II RNase H reverse transcriptase and random
primers (Invitrogen Life Technologies, Rockville, MD). Primers for
quantitative real-time PCR were designed using Primer Express
software (Applied BioSystems Inc., Foster City, CA, ABI) and
synthesized by Integrated DNA Technologies (IDT). The following
primers were used to detect human Fibrillin: forward, 50-CCAATG
GAGCAGATATCGATGA-30; reverse, 50-TTCGGCAAACATCGTGAA
TAAC-30; human CTGF forward, 50-TGTGTGACGAGCCCAAGGA-30;
reverse, 50-TCTGGGCCAAACGTGTCTTC-30; human TGFb forward,
50-CCCTGCCCCTACATTTGGA-30, reverse, 50-CCGGGTTATGCTG
GTTGTACA-30; human Endothelin-1 (ET-1) forward, 50-AGGAAG
AAAAATCAGAAGAAGTTCAGA-30; reverse, 50-CTCCGACCTGGTT
TGTCTTAGG-30, human Smooth muscle actin (SMA) forward,
50-GCCAACCGGGAGAAAATGA-30; reverse, 50-CGCCTGGATAGCC
ACATACA-30. Relative quantification of human Fibrillin, CTGF, ET-1,
TGFb, SMA was measured using SYBR Green chemistry. Taqman
primers for human CCN3/NOV, human control 18S rRNA, mouse
SMA, ET-1, CTGF, TGFb and mouse control GAPDH were
purchased from ABI. TaqMan Master Mix chemistry was used to
detect gene expression in an ABI Prism 7300 Sequence Detector as
recommended by the supplier (ABI). Expression was normalized
to18S rRNA (human) or GAPDH (mouse) and relative expression of
each gene calculated using DDCt formula, choosing a healthy donor
sample as the control (Livak and Schmittgen, 2001).
Wnt-Signaling Pathway PCR Array (SA Biosciences, Frederick,
MD) was performed according to the supplied manufacturer
protocol using SSc and healthy skin cDNAs prepared as above
carried out on an ABI Prism 7700 RT-PCR machine with
results normalized to five housekeeping controls included on
the plate.
TGFb and Wnt promoter-reporter assays
Here, 70% confluent TMLC (TGFb, (Abe et al., 1994)) or LSL
cells (Wnt, (Blitzer and Nusse, 2006)) were treated in DMEM
containing 1% FBS and growth factor(s) to be tested. For assays
of human sera, 10% sera was added. After 24 hours, cells were
rinsed with PBS, lysed with Reporter Lysis Buffer (Luciferase Assay
System, Promega, Madison, WI) and 10 ml of each sample vortexed
with 50 ml of Luciferase Assay Reagent in a disposable cuvette
for light measurement using a luminometer (Turner TD-20e
Luminometer).
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